Joydeep Goswami
to serve as advisor through June
30
Illumina reaffirms Q1 2024 and full-year 2024
financial guidance
SAN
DIEGO, April 9, 2024 /PRNewswire/ -- Illumina,
Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and
array-based technologies, today announced that Joydeep Goswami has decided to leave Illumina.
He will stay on in an advisory role through June 30 to support two new executive management
team appointments.
Ankur Dhingra is joining Illumina
as Chief Financial Officer (CFO), leading Illumina's financial
planning and analysis, accounting, investor relations, internal
audit, tax, and treasury functions. Dhingra brings a breadth of
experience from the life sciences tools, diagnostics, and
pharmaceutical industries. He formerly was CFO at Summit
Therapeutics Inc. (NASDAQ: SMMT), and prior to that was CFO of
CAREDx, Inc. Dhingra spent more than 18 years at Agilent
Technologies, most recently as VP, Investor Relations. Before that,
he held various finance leadership roles with progressively
increasing responsibility, including multiple business unit CFO
roles. He brings experience in developing and executing growth and
margin improvement strategies, delivering P&L commitments, and
driving businesses toward increasing levels of performance. Dhingra
has a demonstrated record of success in executing and influencing
growth-oriented business strategies, as well as managing global
finance and accounting teams. He is a Chartered Accountant and
member of The Institute of Chartered Accountants of India.
Jakob Wedel has been named Chief
Strategy and Corporate Development Officer. Wedel joined Illumina
in November 2023 as CEO Chief of
Staff, leading strategic transformation initiatives. In his new
role, Wedel is responsible for driving Illumina's strategic
planning, partnerships, and acquisitions. Previously, Wedel was
partner at EY's strategy practice, co-leading their global life
science practice, and served in roles at McKinsey & Company and
Bain & Company. In the early 2000s, Wedel co-founded the Nordic
strategy firm QVARTZ, which was later acquired by Bain.
"I am proud of the talent joining our management team as we work
to deliver on Illumina's mission to improve human health by
unlocking the power of the genome," said Jacob Thaysen, Illumina CEO. "Ankur brings deep
financial expertise, investor and leadership experience, and
industry knowledge to Illumina's CFO role, and Jakob has keen
insights gained from 25 years in strategy leadership roles with
global consulting firms. Both are deeply committed to serving our
customers and helping Illumina grow."
Dhingra and Wedel are both relocating to San Diego. They succeed Goswami, who held both
the CFO and Chief Strategy and Corporate Development Officer roles
since early 2023. Goswami joined Illumina in 2019 to lead strategy
and corporate development. He will continue as an advisor to the
company starting April 15 and through
June 30. He departs the organization
on July 1.
"We are grateful to Joydeep for his many contributions to
Illumina over more than four years, and for most recently leading
these two key functions," said Thaysen. "Joydeep will continue with
us for several weeks to support a smooth leadership
transition."
The company has reaffirmed its guidance for the first quarter
2024 and full-year 2024, as announced during its fourth quarter
2023 earnings call on February 8,
2024.
About Illumina
Illumina is improving human health by
unlocking the power of the genome. Our focus on innovation has
established us as a global leader in DNA sequencing and array-based
technologies, serving customers in the research, clinical, and
applied markets. Our products are used for applications in the life
sciences, oncology, reproductive health, agriculture, and other
emerging segments. To learn more, visit illumina.com and
connect with us
on X, Facebook, LinkedIn, Instagram, TikTok,
and YouTube.
Contacts
Investors:
Salli Schwartz
858-291-6421
IR@illumina.com
Media:
David McAlpine
347-327-1336
PR@illumina.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/illumina-appoints-ankur-dhingra-chief-financial-officer-jakob-wedel-chief-strategy-and-corporate-development-officer-302112206.html
SOURCE Illumina, Inc.